948 Results

People

  1. Kris
    Kris
  2. Kelsen
    Kelsen
  3. Motzer
    Motzer
  4. O'Reilly
    O'Reilly
  5. Saltz
    Saltz
  6. Tyson
    Tyson
  7. Gralla
    Gralla
  8. Hudis
    Hudis
  9. Scher
    Scher
  10. Aghajanian
    Aghajanian

Groups

  1. Department of Medicine (633)
  2. Solid Tumor Oncology Division (507)
  3. Gastrointestinal Oncology Service (138)
  4. Survivorship Research (128)
  5. Hematologic Malignancies, Division of (127)
  6. Thoracic Oncology (112)
  7. Center for Hematologic Malignancies (109)
  8. Genitourinary Oncology Service (106)
  9. Nursing (101)
  10. Surgery (97)
  1. "vomiting"
Formats
  1. Journal Article (896)
  2. Review (27)
  3. Conference Paper (8)
  4. Editorial (6)
  5. Research Letter (4)
  6. Correspondence (2)
  7. Guidelines (2)
  8. Book Section (1)
  9. Meeting Abstract (1)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (633)
  2. Solid Tumor Oncology Division (507)
  3. Gastrointestinal Oncology Service (138)
  4. Survivorship Research (128)
  5. Hematologic Malignancies, Division of (127)
  6. Thoracic Oncology (112)

More Groups

People
  1. Mark Kris (70)
  2. David Kelsen (40)
  3. Robert Motzer (39)
  4. Eileen O'Reilly (30)
  5. Leonard Saltz (30)
  6. Leslie Tyson (28)

More People

Years
  1. 2025 (25)
  2. 2024 (63)
  3. 2023 (44)
  4. 2022 (32)
  5. 2021 (15)
  6. 2020 (50)

More Years

Publications
  1. Journal of Clinical Oncology (90)
  2. Cancer (47)
  3. Clinical Cancer Research (44)
  4. Lancet Oncology (38)
  5. Gynecologic Oncology (31)
  6. Cancer Treatment Reports (26)

More Publications

Publishers
  1. Elsevier Inc. (145)
  2. American Society of Clinical Oncology (92)
  3. Elsevier Science, Inc. (74)
  4. Springer (72)
  5. Oxford University Press (64)
  6. Wiley Blackwell (63)

More Publishers

Results (948)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 2 study of idelalisib plus rituximab in treatment-naïve older patients with chronic lymphocytic leukemia
    Journal Article

    O'Brien, S. M.; Lamanna, N.; Kipps, T. J.; Flinn, I.; Zelenetz, A. D.; Burger, J. A.; Keating, M.; Mitra, S.; Holes, L.; Yu, A. S.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancer
    Journal Article

    Nayak, L.; Deangelis, L. M.; Robins, H. I.; Govindan, R.; Gadgeel, S.; Kelly, K.; Rigas, J. R.; Peereboom, D. M.; Rosenfeld, S. S.; Muzikansky, A.; more...
    Cancer (2015)

    Fulltext@MSK | Save
  • Targeted agents for HER2-positive breast cancer: Optimal use in older patients
    Journal Article

    Singh, J. C.; Lichtman, S. M.
    Drugs & Aging (2015)

    Fulltext@MSK | Save
  • Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies
    Journal Article

    Naidoo, J.; Page, D. B.; Li, B. T.; Connell, L. C.; Schindler, K.; Lacouture, M. E.; Postow, M. A.; Wolchok, J. D.
    Annals of Oncology (2015)

    Fulltext@MSK | Save
  • Cabozantinib versus everolimus in advanced renal-cell carcinoma
    Journal Article

    Choueiri, T. K.; Escudier, B.; Powles, T.; Mainwaring, P. N.; Rini, B. I.; Donskov, F.; Hammers, H.; Hutson, T. E.; Lee, J. L.; Peltola, K.; more...
    New England Journal of Medicine (2015)

    Fulltext@MSK | Save
  • Phase II trial of sorafenib in patients with chemotherapy refractory metastatic esophageal and gastroesophageal (GE) junction cancer
    Journal Article

    Janjigian, Y. Y.; Vakiani, E.; Ku, G. Y.; Herrera, J. M.; Tang, L. H.; Bouvier, N.; Viale, A.; Socci, N. D.; Capanu, M.; Berger, M.; more...
    PLoS ONE (2015)

    Fulltext@MSK | Save
  • Efficacy and safety of abiraterone acetate in elderly (75 years or older) chemotherapy naïve patients with metastatic castration resistant prostate cancer
    Journal Article

    Smith, M. R.; Rathkopf, D. E.; Mulders, P. F. A.; Carles, J.; Van Poppel, H.; Li, J.; Kheoh, T.; Griffin, T. W.; Molina, A.; Ryan, C. J.
    Journal of Urology (2015)

    Fulltext@MSK | Save
  • Phase I dose-escalation study of the PI3K/mTOR inhibitor voxtalisib (SAR245409, XL765) plus temozolomide with or without radiotherapy in patients with high-grade glioma
    Journal Article

    Wen, P. Y.; Omuro, A.; Ahluwalia, M. S.; Fathallah-Shaykh, H. M.; Mohile, N.; Lager, J. J.; Laird, A. D.; Tang, J.; Jiang, J.; Egile, C.; more...
    Neuro-Oncology (2015)

    Fulltext@MSK | Save
  • Methotrexate, doxorubicin, and cisplatin (MAP) plus maintenance pegylated interferon alfa-2b versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: First results of the EURAMOS-1 good response randomized controlled trial
    Journal Article

    Bielack, S. S.; Werner, M.; Tunn, P. U.; Helmke, K.; Jürgens, H.; Calaminus, G.; Gerss, J.; Butterfass-Bahloul, T.; Reichardt, P.; Smeland, S.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Hepatic portal venous gas from nonischemic cause: A case report
    Journal Article

    Chen, L.
    Critical Care Nursing Quarterly (2015)

    Fulltext@MSK | Save